NCT01075763View on ClinicalTrials.gov

A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Alzheimer's Disease
Interventions
DRUG

Interferon beta-1a

Interferon (IFN) beta-1a \[Rebif® 22 microgram (mcg), three times per week (tiw)\] administered subcutaneously (sc)

DRUG

Placebo

The inactive substance (placebo) looks the same as Interferon beta-1a (Rebif®), and is given the same way

Trial Locations (1)

95122

U.VA. Neurologia - Azienda Ospedaliera Garibaldi Nesina, Catania

All Listed Sponsors
collaborator

Merck Serono S.P.A., Italy

INDUSTRY

lead

Merck KGaA, Darmstadt, Germany

INDUSTRY

NCT01075763 - A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease | Biotech Hunter | Biotech Hunter